Polyoxidonium 12 mg 10 tabs

Products might cost different amounts at a pharmacy and online. The image of the product may differ from the actual product.

The drug should be used only according to the indications, the method of administration and in the doses indicated in the instructions. If there is no improvement after treatment or the symptoms worsen or new symptoms appear, you should consult your doctor.

Orally and sublingually, 20–30 minutes before meals, 2 times a day daily.

Children over 10 years old and adults - 1 tablet, children from 3 to 10 years old - 1/2 tablet (6 mg).

If necessary, repeated courses of therapy are possible after 3–4 months.

When the drug is re-prescribed, its effectiveness does not decrease.

Recommended treatment regimens

Sublingual

For treatment in adults:

- influenza and acute respiratory infections - 1 tablet 2 times a day for 7 days;

- inflammatory processes of the oropharynx - 1 tablet 2 times a day for 10 days;

- exacerbations of chronic diseases of the upper respiratory tract, paranasal sinuses, chronic otitis media - 1 tablet 2 times a day for 10 days;

- allergic diseases (including hay fever, bronchial asthma), complicated by recurrent bacterial, fungal and viral infections - 1 tablet 2 times a day for 10 days.

For treatment in children from 3 to 10 years:

- influenza and acute respiratory infections - 1/2 tablet 2 times a day for 7 days;

- inflammatory processes of the oropharynx - 1/2 tablet 2 times a day for 7 days;

- allergic diseases (including hay fever, bronchial asthma), complicated by recurrent bacterial, fungal and viral infections - 1/2 tablet 2 times a day for 7 days.

For treatment in children over 10 years of age:

- influenza and acute respiratory infections - 1 tablet 2 times a day for 7 days;

- inflammatory processes of the oropharynx - 1 tablet 2 times a day for 7 days;

- exacerbations of chronic diseases of the upper respiratory tract, paranasal sinuses, chronic otitis media - 1 tablet 2 times a day for 7 days;

- allergic diseases (including hay fever, bronchial asthma), complicated by recurrent bacterial, fungal and viral infections - 1 tablet 2 times a day for 7 days.

For prevention in adults:

- influenza and acute respiratory infections in the pre-epidemic period - 1 tablet per day for 10 days;

- recurrent herpetic infection of the nasal and labial area - 1 tablet 2 times a day for 10 days;

- exacerbations of chronic foci of infections of the oropharynx, paranasal sinuses, upper respiratory tract, inner and middle ear - 1 tablet 1 time per day for 10 days;

- secondary immunodeficiencies arising due to aging or exposure to adverse factors - 1 tablet 1 time per day for 10 days.

For prevention in children aged 3 to 10 years:

- influenza and acute respiratory infections in the pre-epidemic period - 1/2 tablet per day for 7 days;

- recurrent herpetic infection of the nasal and labial area - 1/2 tablet 2 times a day for 7 days;

- exacerbations of chronic foci of infections of the oropharynx, paranasal sinuses, upper respiratory tract, inner and middle ear - 1/2 tablet once a day for 10 days.

For prevention in children over 10 years of age:

- influenza and acute respiratory infections in the pre-epidemic period - 1 tablet per day for 7 days;

- recurrent herpetic infection of the nasal and labial area - 1 tablet 2 times a day for 7 days;

- exacerbations of chronic foci of infections of the oropharynx, paranasal sinuses, upper respiratory tract, inner and middle ear, 1 tablet once a day for 10 days.

Orally

For treatment in adults and children over 10 years of age:

- diseases of the upper and lower respiratory tract - 1 tablet 2 times 10 days.

Contraindications
increased individual sensitivity;
pregnancy;
breastfeeding period;
children under 3 years of age;
acute renal failure;
rare hereditary lactose intolerance, lactase deficiency, glucose-galactose malabsorption;
With caution: chronic renal failure (use no more than 2 times a week).

Use during pregnancy and breastfeeding
The use of the drug Polyoxidonium® is contraindicated for pregnant women and women during breastfeeding (there is no clinical experience of use). An experimental study of the drug Polyoxidonium® in animals did not reveal embryotoxic or teratogenic effects or effects on fetal development.

Before using the drug Polyoxidonium®, if the patient is pregnant or planning pregnancy, you should consult your doctor.

During breastfeeding, you should consult your doctor before using Polyoxidonium®.

The customer is responsible for making informed decisions about purchasing and using these products. Any reliance on the information provided herein or the use of products sold on this website is solely at the customer's own risk.
Please read our Healthcare Disclaimer.